27 completed, 10 unknown, 2 active not recruiting, 2 recruiting. 44 Phase 1, 22 Phase 2.
Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old allogeneic mesenchymal stem cells, Placebo - Urinary Incontinence Stress | Phase 1 | Recruiting | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 60 | 2024-12-16 | 2026-11-02 |
| Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients Primary human muscle stem cells (Satori-01), Placebo - Urinary Incontinence, Epispadias, Male | Phase 1 / Phase 2 | Not yet recruiting | Simone Spuler, MD | 21 | 2024-06-01 | 2023-08-03 |
| Reduced-dose Botox for Urgency Incontinence Among Elder Females Botox 50 Unit Injection, Botox 100 Unit Injection - Overactive Bladder, Urinary Incontinence in Old Age | Phase 1 / Phase 2 | Active not recruiting | Dartmouth-Hitchcock Medical Center | 376 | 2023-05-12 | 2026-02-03 |
| Effects of Single Dose Tadalafil on Urethral and Anal Closure Function Tadalafil 40 MG, Placebo - Urinary Incontinence,Stress, Fecal Incontinence | Phase 1 | Completed | University Hospital Bispebjerg and Frederiksberg | 24 | 2021-08-01 | 2022-04-06 |
| Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS Valacyclovir - Pain, Chronic, Urge Incontinence | Phase 1 | Unknown | Buddhist Tzu Chi General Hospital | 30 | 2021-07-01 | 2021-10-26 |
| Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells Autologous adipose-derived mesenchymal stem cells, Standard treatment according to the Clinical protocols - Urinary Incontinence | Phase 1 / Phase 2 | Completed | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 10 | 2020-08-01 | 2021-05-25 |
| Multisystem Cell Therapy for Improvement of Urinary Continence Muscle Precursor Cells (MPCs), ATMP - Urinary Stress Incontinence | Phase 1 | Completed | University of Zurich | 10 | 2020-01-22 | 2021-11-03 |
| Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet - Stress Urinary Incontinence, Fecal Incontinence | Phase 1 | Completed | University Hospital Bispebjerg and Frederiksberg | 24 | 2019-09-17 | 2021-06-09 |
| DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence Litoxetine, placebo - Urinary Incontinence | Phase 1 / Phase 2 | Completed | Ixaltis SA | 84 | 2018-04-03 | 2020-06-11 |
| Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells Autologous adipose-derived mesenchymal stem cells, Standard treatment according to the Clinical protocols - Stress Urinary Incontinence | Phase 1 / Phase 2 | Completed | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 10 | 2018-03-01 | 2020-06-25 |
| Mirabegron For Erectile Dysfunction Mirabegron - Erectile Dysfunction, Overactive Bladder | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 20 | 2017-08-01 | 2021-01-05 |
| Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? Placebo Oral Tablet, Imipramine Hydrochloride 25 MG - Urinary Incontinence, Stress, Fecal Incontinence | Phase 1 | Completed | Jonatan Kornholt | 16 | 2017-05-16 | 2021-02-12 |
| Tissue Bonding Cystostomy(TBC) TBC - Spinal Cord Injury (SCI), Chronic Urinary Retention | Phase 1 | Unknown | Uro-Research, LLC | 10 | 2017-05-01 | 2016-05-11 |
| Use of Sildenafil for Treatment of Urinary Incontinence Sildenafil, Placebo - Urinary Incontinence | Phase 1 | Active not recruiting | The University of Texas Medical Branch, Galveston | 24 | 2017-03-10 | 2026-08-06 |
| Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence MDC - Bladder Exstrophy, Urinary Incontinence | Phase 1 | Terminated | Johns Hopkins University | 2 | 2017-02-01 | 2020-01-28 |
| Autologous Muscle Derived Cells for Underactive Bladder Autologous Muscle Derived Cells - Urinary Retention, Urinary Incontinence | Phase 1 | Completed | Jason Gilleran | 23 | 2016-11-16 | 2022-01-19 |
| Muscle Fiber Fragment Treatment for Urinary Incontinence Autologous Muscle Fiber Fragments - Urinary Incontinence | Phase 1 / Phase 2 | Recruiting | Wake Forest University | 10 | 2016-01-01 | 2026-04-23 |
| A Study of TAS-303 in Female Patients With Stress Urinary Incontinence TAS-303 18mg single-dose, Placebo 18mg single-dose, TAS-303 9mg single-dose - Stress Urinary Incontinence | Phase 1 | Completed | Taiho Pharmaceutical Co., Ltd. | 16 | 2015-10-01 | 2016-08-10 |
| Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery autologous muscle-derived cells (AMDC) - Urinary Incontinence, Stress | Phase 1 / Phase 2 | Completed | Cook MyoSite | 25 | 2015-02-19 | 2021-11-01 |
| Advanced Pelvic Floor Training Program for Prostate Cancer Surgery Advanced Pelvic Floor Muscle Exercise (APFX) - Prostate Cancer Patients Undergoing Radical Prostatectomy | Phase 1 / Phase 2 | Completed | University of Guelph-Humber | 88 | 2015-01-01 | 2017-10-26 |
Showing 20 of 44. Sign in to see all of them.
Urinary Incontinence, Stress (15) · Urinary Incontinence, Urge (7) · Urinary Bladder, Overactive (6) · Fecal Incontinence (4) · Lower Urinary Tract Symptoms (3) · Bladder Exstrophy (2) · Spinal Cord Injuries (2) · Bladder Exstrophy and Epispadias Complex (1) · Chronic Pain (1) · Cystocele (1) · Encopresis (1) · Epispadias (1) · Erectile Dysfunction (1) · Gastrointestinal Diseases (1)
Female Urogenital Diseases (44) · Female Urogenital Diseases and Pregnancy Complications (44) · Male Urogenital Diseases (44) · Pathological Conditions, Signs and Symptoms (44) · Signs and Symptoms (44) · Urogenital Diseases (44) · Urination Disorders (43) · Urologic Diseases (43) · Urological Manifestations (43) · Lower Urinary Tract Symptoms (41) · Urinary Bladder Diseases (10) · Digestive System Diseases (4) · Genital Diseases (4) · Congenital Abnormalities (3)
Solifenacin Succinate (3) · mirabegron (3) · fesoterodine (2) · Botulinum Toxins, Type A (1) · Citalopram (1) · Fluconazole (1) · Imipramine (1) · Reboxetine (1) · Sildenafil Citrate (1) · TAS-303 (1) · Tadalafil (1) · Tamsulosin (1) · Valacyclovir (1) · cyclic adenosine-5'-trimetaphosphate (1) · litoxetine (1)
Astellas Pharma Inc (2) · Cook MyoSite (2) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (2) · Johns Hopkins University (2) · Klinikum der Universität Köln (2) · University Hospital Bispebjerg and Frederiksberg (2) · Wake Forest University (2) · Al-Azhar University (1) · Assistance Publique - Hôpitaux de Paris (1) · Astellas Pharma Europe B.V. (1) · Beech Tree Labs, Inc. (1) · Bio-Medical Research, Ltd. (1) · Buddhist Tzu Chi General Hospital (1) · Burnasyan Federal Medical Biophysical Center (1) · Carbon Medical Technologies (1)
United States (16) · Denmark (5) · Germany (4) · Belarus (2) · Canada (2) · Japan (2) · Spain (2) · Taiwan (2) · Egypt (1) · France (1) · Greece (1) · Israel (1) · Netherlands (1) · Russia (1) · Slovenia (1)
Gopal Badlani, MD (2) · Wolfram H Jager, PhD (2) · Abd-Elmoneim Shawky Shams El-deen, MD (1) · Abdel-Wahab El-Okby, MD (1) · Ahmed Said Sayed Bayomy, MSc (1) · Alexander Nechiporenko, Dr (1) · Anne C Cooper, MD, MA (1) · Anne K Ebert, Prof. Dr. (1) · Arthur L Burnett, M.D., M.B.A. (1) · Christopher P. Smith, MD (1) · Daniel Eberli, Prof (1) · Dean Klein (1)
PMID 22342057, PMID 26377550, PMID 37144409, PMID 38456894, PMID 38540138, PMID 39076155, PMID 39167201
2009 (1), 2019 (1), P50HD044406 (1)